Trailblazer, Advocate, Innovator and Clinician For Patients With Metastatic Breast Cancer
A colleague recognizes the generosity, humility and grace of a metastatic breast cancer expert who has led many practice-changing trials and programs to help as many patients as she can.
Dr. Nancy U. Lin is most deserving of this award. It is hard to find the words to describe how much she has done for the metastatic breast cancer community, including patients, caregivers, researchers and clinicians. She also does everything with grace, humility, generosity and kind- ness, and is a true mensch and friend in every aspect of what she has done and continues to do.
Dr. Rachel Freedman. Photo provided by Dana-Farber Cancer Institute.
To give you a sense of what she has accomplished to date: Dr. Lin is an international expert in the care of patients with metastatic breast cancer. She has led many high-impact, practice-changing clinical trials, runs the metastatic disease program at Dana-Farber Cancer Institute and is a staunch supporter and advocate for developing and nurturing optimal ways of caring for patients. She leads our central nervous system metastatic program at Dana-Farber and is a mentor to many on how to build programs, run trials, think about research and deliver the highest-quality care to patients with this disease.
She built the EMBRACE program (Ending Metastatic Breast Cancer for Everyone) at our center from the ground up. EMBRACE is both a clinical and research program for patients with metastatic breast cancer. Patients enrolled to EMBRACE are offered a unique package of services, support groups, research opportunities and educational forums and are a part of a large registry that allows us to track patients for prescreening of studies, possible opportunities for clinical trials and understanding patterns of care and tumor genomics.
Nancy continues to push the limits of what is available to our patients, is constantly evolving and innovating around caring for patients with metastatic breast cancer and is the most collegial, kind, supportive colleague you could hope for. Her work really deserves this special recognition. I truly believe there is no one on the planet doing more for patients with metastatic breast cancer than Dr. Nancy Lin. Thank you for considering her for this award.
For more news on cancer updates, research and education, don’t forget to subscribe to CURE®’s newsletters here.
FDA, Cancer Vaccine Updates and a Misguiding of Breast Cancer Treatment
February 5th 2024One cancer vaccine may still be years away from being available, a breast cancer test may be misguiding treatments for Black women and the review of two oncology regimens are being expedited by the FDA.
Listen
